Research & Literature

Treating elderly patients with ANCA-associated vasculitis.

Jefferson JA

Clinical journal of the American Society of Nephrology : CJASN 2015; (10(7)):1110-3 doi:10.2215/CJN.05350515.

Risk factors associated with relapse or infectious complications in Japanese patients with microscopic polyangiitis.

Kitagawa K, Furuichi K, Sagara A, et al.

Clinical and experimental nephrology 2016; (20(5)):703-711 doi:10.1007/s10157-015-1199-7.

Myeloperoxidase anti-neutrophil cytoplasmic antibody affinity is associated with the formation of neutrophil extracellular traps in the kidney and vasculitis activity in myeloperoxidase anti-neutrophil cytoplasmic antibody-associated microscopic polyangiitis.

Yoshida M, Yamada M, Sudo Y, et al.

Nephrology (Carlton, Vic.) 2016; (21(7)):624-9 doi:10.1111/nep.12736.

Presence of Citrullinated Histone H3-Positive Neutrophils in Microscopic Polyangiitis from the Early Phase: An Autopsy Proven Case.

Matsuda Y, Hamayasu H, Seki A, et al.

Pathology international 2016; (66(8)):466-71 doi:10.1111/pin.12434.

The clinical presentation and therapy of diseases related to anti-neutrophil cytoplasmic antibodies (ANCA).

Weiner M, Segelmark M

Autoimmunity reviews 2016; (15(10)):978-82.

Neutrophil extracellular traps in neuropathy with anti-neutrophil cytoplasmic autoantibody-associated microscopic polyangiitis.

Takeuchi H, Kawasaki T, Shigematsu K, et al.

Clinical rheumatology 2017; (36(4)):913-917 doi:10.1007/s10067-017-3546-4.

ANCA Associated Mononeuritis Multiplex with Overlap in Vasculitic Syndromes.

Anadure R, Narayanan C, Varadraj G, Nandeesh B

Journal of clinical and diagnostic research : JCDR 2017; (11(1)):OD01-OD03 doi:10.7860/JCDR/2017/22252.9149.

Randomised controlled trial of prolonged treatment in the remission phase of ANCA-associated vasculitis.

Karras A, Pagnoux C, Haubitz M, et al.

Annals of the rheumatic diseases 2017; (76(10)):1662-1668 doi:10.1136/annrheumdis-2017-211123.

Cutaneous Manifestations of ANCA-Associated Small Vessels Vasculitis.

Marzano AV, Raimondo MG, Berti E, et al.

Clinical reviews in allergy & immunology 2017; (53(3)):428-438 doi:10.1007/s12016-017-8616-5.

Clinical and pathological features of anti-neutrophil cytoplasmic antibody-associated vasculitis in patients with minor urinary abnormalities.

Hasegawa J, Hoshino J, Sekine A, et al.

Nephrology (Carlton, Vic.) 2018; (23(11)):1007-1012 doi:10.1111/nep.13157.

Cardiovascular events in anti-neutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis of observational studies.

Houben E, Penne EL, Voskuyl AE, et al.

Rheumatology (Oxford, England) 2018; (57(3)):555-562 doi:10.1093/rheumatology/kex338.

From fibrosis to diagnosis: a paediatric case of microscopic polyangiitis and review of the literature.

Roszkiewicz J, Smolewska E

Rheumatology international 2018; (38(4)):683-687 doi:10.1007/s00296-017-3923-y.

The Utility of Urinalysis in Determining the Risk of Renal Relapse in ANCA-Associated Vasculitis.

Rhee RL, Davis JC, Ding L, et al.

Clinical journal of the American Society of Nephrology : CJASN 2018; (13(2)):251-257 doi:10.2215/CJN.04160417.

Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitides.

Terrier B, Pagnoux C, Perrodeau É, et al.

Annals of the rheumatic diseases 2018; (77(8)):1150-1156 doi:10.1136/annrheumdis-2017-212768.

Microscopic Polyangiitis: New Insights into Pathogenesis, Clinical Features and Therapy.

Karras A

Seminars in respiratory and critical care medicine 2018; (39(4)):459-464 doi:10.1055/s-0038-1673387.

Investigations in systemic vasculitis. The role of the laboratory.

Csernok E, Bossuyt X

Best practice & research. Clinical rheumatology 2018; (32(1)):52-62 doi:10.1016/j.berh.2018.07.005.

Renal relapse in antineutrophil cytoplasmic autoantibody-associated vasculitis: unpredictable, but predictive of renal outcome.

Wester Trejo MAC, Floßmann O, Westman KW, et al.

Rheumatology (Oxford, England) 2019; (58(1)):103-109 doi:10.1093/rheumatology/key260.

Distinction between MPO-ANCA and PR3-ANCA-associated glomerulonephritis in Chinese patients: a retrospective single-center study.

Hong Y, Shi P, Liu X, et al.

Clinical rheumatology 2019; (38(6)):1665-1673 doi:10.1007/s10067-019-04458-9.

Incidence and prevalence of granulomatosis with polyangiitis and microscopic polyangiitis in health management organization in Argentina: a 15-year study.

Pierini FS, Scolnik M, Scaglioni V, et al.

Clinical rheumatology 2019; (38(7)):1935-1940 doi:10.1007/s10067-019-04463-y.

Clinical features and prognosis of microscopic polyangiitis with usual interstitial pneumonia compared with idiopathic pulmonary fibrosis.

Zhao W, Dai H, Liu Y, et al.

The clinical respiratory journal 2019; (13(7)):460-466 doi:10.1111/crj.13032.

Management of ANCA-Associated Vasculitis in Pregnancy: Case Report and Review of the Literature.

Raza SH, Sabghi R, Kuperman M, et al.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2021; (27(4)):e146-e149 doi:10.1097/RHU.0000000000000911.

All-cause and cause-specific mortality in ANCA-associated vasculitis: overall and according to ANCA type.

Wallace ZS, Fu X, Harkness T, et al.

Rheumatology (Oxford, England) 2020; (59(9)):2308-2315 doi:10.1093/rheumatology/kez589.

Microscopic Polyangiitis with Pulmonary Fibrosis: An Often-Recognized Manifestation of the Disease.

Clifford LM, Li J, Renaud CJ, Fernando SL

Case reports in rheumatology 2019; (2019()):2673947 doi:10.1155/2019/2673947.

Clinical associations of renal involvement in ANCA-associated vasculitis.

Kronbichler A, Shin JI, Lee KH, et al.

Autoimmunity reviews 2020; (19(4)):102495 doi:10.1016/j.autrev.2020.102495.

Differential clinicopathologic features of EGPA-associated neuropathy with and without ANCA.

Nishi R, Koike H, Ohyama K, et al.

Neurology 2020; (94(16)):e1726-e1737 doi:10.1212/WNL.0000000000009309.

Microscopic polyangiitis: Clinical characteristics and long-term outcomes of 378 patients from the French Vasculitis Study Group Registry.

Nguyen Y, Pagnoux C, Karras A, et al.

Journal of autoimmunity 2020; (112()):102467 doi:10.1016/j.jaut.2020.102467.

[ANCA diagnostics in vasculitis].

Csernok E, Hellmich B

Zeitschrift fur Rheumatologie 2020; (79(7)):669-678 doi:10.1007/s00393-020-00805-3.

New therapeutic strategies in lung vasculitis.

Nasser M, Cottin V

Current opinion in pulmonary medicine 2020; (26(5)):496-506 doi:10.1097/MCP.0000000000000693.

Renal involvement in eosinophilic granulomatosis with polyangiitis (EGPA): a multicentric retrospective study of 63 biopsy-proven cases.

Durel CA, Sinico RA, Teixeira V, et al.

Rheumatology (Oxford, England) 2021; (60(1)):359-365 doi:10.1093/rheumatology/keaa416.

Relapse rate and renal prognosis in ANCA-associated vasculitis according to long-term ANCA patterns.

Oristrell J, Loureiro-Amigo J, Solans R, et al.

Clinical and experimental immunology 2021; (203(2)):209-218 doi:10.1111/cei.13530.

Clinical characteristics and prognosis in 269 patients with antineutrophil cytoplasimc antibody associated vasculitis.

Wu T, Zhong Y, Zhou Y, et al.

Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 2020; (45(8)):916-922 doi:10.11817/j.issn.1672-7347.2020.190436.

Adjunctive Treatment With Avacopan, an Oral C5a Receptor Inhibitor, in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Merkel PA, Niles J, Jimenez R, et al.

ACR open rheumatology 2020; (2(11)):662-671 doi:10.1002/acr2.11185.

Comorbidities and health-related quality of life in Patients with Antineutrophil Cytoplasmic Antibody (ANCA) - associated vasculitis.

Mercuzot C, Letertre S, Daien CI, et al.

Autoimmunity reviews 2021; (20(1)):102708 doi:10.1016/j.autrev.2020.102708.

Plasma exchange for the management of ANCA-associated vasculitis: the con position.

Specks U, Fussner LA, Cartin-Ceba R, et al.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2021; (36(2)):231-236 doi:10.1093/ndt/gfaa312.

Avacopan for the Treatment of ANCA-Associated Vasculitis.

Jayne DRW, Merkel PA, Schall TJ, et al.

The New England journal of medicine 2021; (384(7)):599-609 doi:10.1056/NEJMoa2023386.

Pathogenesis and pathology of anti-neutrophil cytoplasmic antibody（ANCA）-associated vasculitis.

Tsukui D, Kimura Y, Kono H

Journal of translational autoimmunity 2021; (4()):100094 doi:10.1016/j.jtauto.2021.100094.

Effect of Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab on Remission Induction in ANCA-Associated Vasculitis: A Randomized Clinical Trial.

Furuta S, Nakagomi D, Kobayashi Y, et al.

JAMA 2021; (325(21)):2178-2187 doi:10.1001/jama.2021.6615.

Increased prevalence rate of metabolic syndrome is an independent predictor of cardiovascular disease in patients with antineutrophil cytoplasmic antibody-associated vasculitis.

Lee SB, Kwon HC, Kang MI, et al.

Rheumatology international 2022; (42(2)):291-302 doi:10.1007/s00296-021-04908-1.

2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Chung SA, Langford CA, Maz M, et al.

Arthritis care & research 2021; (73(8)):1088-1105 doi:10.1002/acr.24634.

Therapeutic Plasma Exchange: A Lifesaving Therapy in Case of ANCA-associated Vasculitis with Diffuse Alveolar Hemorrhage.

Tripathi PP, Sharma RR, Chhabria B, et al.

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine 2021; (25(7)):828-829 doi:10.5005/jp-journals-10071-23889.

2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Microscopic Polyangiitis.

Suppiah R, Robson JC, Grayson PC, et al.

Arthritis & rheumatology (Hoboken, N.J.) 2022; (74(3)):400-406 doi:10.1002/art.41983.

Clinical Characteristics and Outcomes of Patients With ANCA-Associated Vasculitides in a Colombian Hospital.

Santacruz-Sandoval E, López-Bonilla J, Guevara-Calderón LA, et al.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2022; (28(2)):e491-e497 doi:10.1097/RHU.0000000000001775.

Prevalence of Mental Disorders in Patients With Chronic Thromboembolic Pulmonary Hypertension.

Dering MR, Lepsy N, Fuge J, et al.

Frontiers in psychiatry 2022; (13()):821466 doi:10.3389/fpsyt.2022.821466.

Kidney biopsy in patients with antineutrophil cytoplasmic antibody-associated vasculitis with mild renal abnormality.

Akao S, Yamagiwa G, Hazue R, et al.

CEN case reports 2023; (12(1)):50-55 doi:10.1007/s13730-022-00719-w.

Prevalence of psychological distress among cancer patients in Southeast Asian countries: A systematic review.

Ostovar S, Modarresi Chahardehi A, Mohd Hashim IH, et al.

European journal of cancer care 2022; (31(6)):e13669 doi:10.1111/ecc.13669.

De Novo Vasculitis after COVID-19 Vaccination.

Tang X, Liu F, Li Q, et al.

Current rheumatology reviews 2023; (19(2)):151-158 doi:10.2174/1573397118666220817092235.

Systematic review and meta-analysis for 2023 clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of ANCA-associated vasculitis.

Watanabe R, Oshima M, Nishioka N, et al.

Modern rheumatology 2023; (33(5)):982-989 doi:10.1093/mr/roac114.

A Review of Anti-IL-5 Therapies for Eosinophilic Granulomatosis with Polyangiitis.

Koike H, Nishi R, Yagi S, et al.

Advances in therapy 2023; (40(1)):25-40 doi:10.1007/s12325-022-02307-x.

Ocular manifestations of ANCA-associated vasculitis.

Junek ML, Zhao L, Garner S, et al.

Rheumatology (Oxford, England) 2023; (62(7)):2517-2524 doi:10.1093/rheumatology/keac663.

Monitoring disease activity in antineutrophil antibody-associated vasculitis.

Scurt FG, Hirschfeld V, Schubert L, et al.

Scandinavian journal of immunology 2023; (98(1)):e13284 doi:10.1111/sji.13284.

Clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of microscopic polyangiitis and granulomatosis with polyangiitis: The 2023 update - secondary publication.

Sada KE, Nagasaka K, Kaname S, et al.

Modern rheumatology 2024; (34(3)):559-567 doi:10.1093/mr/road081.

The impact of reclassification by the 2022 ACR/EULAR classification criteria on risk factors for relapse in patients with ANCA-associated vasculitis.

van Leeuwen JR, Hafemann S, van der Boog P, et al.

Clinical kidney journal 2023; (16(12)):2754-2756 doi:10.1093/ckj/sfad225.

The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial.

Strand V, Jayne DRW, Horomanski A, et al.

The Lancet. Rheumatology 2023; (5(8)):e451-e460 doi:10.1016/S2665-9913(23)00092-9.

Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Active Kidney Involvement in the United States: 2016-2020.

Tao J, Liu S, Montez-Rath M, et al.

Glomerular diseases 2024; (4(1)):33-42 doi:10.1159/000536168.

Diagnosis and management of ANCA-associated vasculitis.

Kronbichler A, Bajema IM, Bruchfeld A, et al.

Lancet (London, England) 2024; (403(10427)):683-698 doi:10.1016/S0140-6736(23)01736-1.

Pathogenesis of Pulmonary Manifestations in ANCA-Associated Vasculitis and Goodpasture Syndrome.

Fouka E, Drakopanagiotakis F, Steiropoulos P

International journal of molecular sciences 2024; (25(10)) doi:10.3390/ijms25105278.

ANCA-Negative Pauci-Immune Glomerulonephritis Associated with Bartonella Endocarditis.

Ng C, Penney A, Sharaflari R, et al.

Case reports in nephrology 2024; (2024()):4181660 doi:10.1155/2024/4181660.

Microscopic polyangiitis presenting as idiopathic pulmonary fibrosis.

Duchene B

Respiratory medicine case reports 2024; (52()):102122 doi:10.1016/j.rmcr.2024.102122.

Avacopan as an add-on therapy for ANCA-associated vasculitis: a pharmacological overview.

Tesar V, Hartinger JM, Hruskova Z

Expert review of clinical pharmacology 2024; (17(12)):1099-1113 doi:10.1080/17512433.2024.2432500.

Treatment With Avacopan in Patients With Respiratory Tract Manifestations of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Specks U, Spiera RF, Fussner LA, et al.

ACR open rheumatology 2025; (7(1)):e11795 doi:10.1002/acr2.11795.

Recommendations for the diagnosis and treatment of anti-neutrophil cytoplasmic autoantibody associated vasculitis.

Morales E, Rúa-Figueroa I, Callejas Rubio JL, et al.

Nefrologia 2025; (45(1)):15-58 doi:10.1016/j.nefroe.2025.01.001.

Myeloperoxidase anti-neutrophil cytoplasmic antibody-associated vasculitis with silicosis, alveolar hemorrhage, and rapidly progressive glomerulonephritis: a case report.

Mizuhashi K

AME case reports 2025; (9()):8 doi:10.21037/acr-24-112.

Practical Management of ANCA-Associated Vasculitis: A Clinician's Perspective.

Stacey HL, Francis L, Smith RM, Jones RB

Glomerular diseases 2025; (5(1)):84-102 doi:10.1159/000543159.

Does plasma exchange have a role in ANCA-associated vasculitis? Viewpoint 2: plasma exchange may be useful under some circumstances.

Odler B, Kronbichler A, Szpirt WM

Rheumatology (Oxford, England) 2025; (64(Supplement_1)):i68-i70 doi:10.1093/rheumatology/keae612.

Simplifying ANCA-associated vasculitis classification with ANCA specificity: a retrospective analysis.

Zhang L, Zhang J, Xu J, et al.

Clinical rheumatology 2025; (44(5)):1999-2008 doi:10.1007/s10067-025-07397-w.

Health-related quality of life and work productivity in Japanese patients with primarily stable ANCA-associated vasculitis: A multicenter cross-sectional study.

Hirahara S, Katsumata Y, Sada KE, et al.

Modern rheumatology 2025; (35(6)):974-980 doi:10.1093/mr/roaf044.

Overlap or Outlier? Granulomatosis With Polyangiitis With Eosinophilia: A Case Report and Diagnostic Insight.

Zeleke ST, Zaidi SR, Gebremedhen AI, Becker M

Journal of investigative medicine high impact case reports 2025; (13()):23247096251363027 doi:10.1177/23247096251363027.

Granulicatella adiacens Endocarditis Mimicking an Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Cukierkorn EL, de Los Santos Fortuna G, Salvetti Valente F, et al.

JACC. Case reports 2025; (30(21)):104409 doi:10.1016/j.jaccas.2025.104409.

Microscopic polyangiitis with isolated cardiopulmonary involvement: A case report.

Chen J, Zhang L, Huang Z, Zhu D

Medicine 2025; (104(38)):e44659 doi:10.1097/MD.0000000000044659.

Mapping a path forward: addressing disease burden, pathways and solutions in ANCA-associated vasculitis.

Hellmich B

Rheumatology (Oxford, England) 2026; (65(Supplement_1)):i1-i5 doi:10.1093/rheumatology/keaf517.

Efficacy and safety of avacopan for treatment of patients with ANCA-associated vasculitis receiving cyclophosphamide.

Geetha D, Neumann T, Karras A, et al.

RMD open 2025; (11(4)) doi:10.1136/rmdopen-2025-005743.

Factors associated with pauci-immune glomerulonephritis in patients undergoing kidney biopsy with positive anti-neutrophil cytoplasmic antibody results.

Lee YJ, Lee J, Ahn SM, et al.

Journal of nephrology 2025; (38(9)):2919-2928 doi:10.1007/s40620-025-02430-2.

Microscopic Polyangiitis with Alveolar Hemorrhage Complicated by Myasthenia Gravis.

Suzuki E, Sumichika Y, Imaizumi M, Kanno T

Internal medicine (Tokyo, Japan) 2026; (65(11)):1560-1565 doi:10.2169/internalmedicine.5925-25.

Hemoptysis as the initial presentation of ANCA-associated vasculitis in a patient with ulcerative colitis: a case report and literature review.

Fan MH, Wu J, Min CC, et al.

Clinical rheumatology 2026; (45(3)):2089-2095 doi:10.1007/s10067-025-07878-y.

Recent pathogenetic insights and therapeutic advances in ANCA-associated vasculitis.

Sagy I, Jayne DRW

Annals of the rheumatic diseases 2026; (85(4)):588-602 doi:10.1016/j.ard.2025.11.024.

ANCA-associated vasculitis in the United Arab Emirates: a 17-year case series with review from Gulf literature.

Shahrour H, Luqman N, AlKindi F, et al.

Annals of Saudi medicine 2026; (46(1)):20-31 doi:10.5144/0256-4947.2026.20.

Clinical utility of proteinase 3-antineutrophil cytoplasmic antibody at diagnosis in predicting subsequent relapse in patients with microscopic polyangiitis.

Ha JW, Kwon OC, Park YB, Lee SW

Frontiers in medicine 2025; (12()):1745280 doi:10.3389/fmed.2025.1745280.

The diagnostic pathway and time to diagnosis in ANCA-associated vasculitis: a retrospective study at a tertiary rheumatology center.

Bussmann P, Kiltz U, Kavruk H, et al.

Clinical rheumatology 2026; (45(6)):3565-3573 doi:10.1007/s10067-026-08057-3.

Effective Performance of the 2022 American College of Rheumatology/EULAR Classification Criteria for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Pediatric Patients: An ARChiVe Study.

Cabral DA, Bosman ES, McPhate N, et al.

Arthritis & rheumatology (Hoboken, N.J.) 2026; doi:10.1002/art.70172.